Quick Links
Search by Keyword
Search or browse for technologies available for licensing.
Find Technologies
|
Method for Reducing the Atherogenic Risk Factor (LDL) through the Therapeutic Delivery of a Recombinant Protein that Allows the Liver to Change the Type of Protein It Secretes into the Blood
|
Harold Smith, Ph.D. (website)
|
|
Targeting of Cytoprotective Antioxidants to Mitochondria
|
Shey-Shing Sheu, PhD (website)
Marion Anders
Lin Xu
Virendra Sharma
|
|
Androgen Receptor's Involvement in the Development of Type II Diabetes
|
Chawnshang Chang, Ph.D. (website)
HungYun Lin
|
|
Aryloxypropanoic Acids-Based Mitochondrially Targeted Prodrugs. I. Phenol and Pyridinol-Based Antioxidants
|
Marion Anders
|
|
Method for Attenuating Mitochondria-Mediated Cell Injury
|
Paul Brookes, Ph.D. (website)
Marion Anders
Shey-Shing Sheu, PhD (website)
|
|
AlternateTherapeutic Strategies for the Reduction of Serum LDL Cholesterol and the Associated Risk of Atherosclerosis
|
Harold Smith, Ph.D. (website)
|
|
Alternative Treatment of High Cholesterol and Triglycerides, and Other Dyslipidemias via Inhibition of Intestinal Bile Acid Absorption
|
Ned Ballatori, Ph.D. (website)
Na Li
|
|
The TR4 Ligand - New opportunities for the treatment of metabolic syndrome, diabetes and cardiovascular diseases and, possible drug screening to eliminate the side effects of PPARs
|
Chawnshang Chang, Ph.D. (website)
|
|
Human Biliverdin Reductase-Based Peptides and their Potential Role in Treating Diabetes and Hypoglycemia
|
Mahin Maines, Ph.D.
|
Discover the Future
Stay Informed
Subscribe to the Technology Transfer RSS feed, and be notified when new topics are added to our Technology listings.
